Molecular networks in Network Medicine: Development and applications

Abstract

Network Medicine applies network science approaches to investigate disease pathogenesis. Many different analytical methods have been used to infer relevant molecular networks, including protein-protein interaction networks, correlation-based networks, gene regulatory networks, and Bayesian networks. Network Medicine applies these integrated approaches to Omics Big Data (including genetics, epigenetics, transcriptomics, metabolomics, and proteomics) using computational biology tools and, thereby, has the potential to provide improvements in the diagnosis, prognosis, and treatment of complex diseases. We discuss briefly the types of molecular data that are used in molecular network analyses, survey the analytical methods for inferring molecular networks, and review efforts to validate and visualize molecular networks. Successful applications of molecular network analysis have been reported in pulmonary arterial hypertension, coronary heart disease, diabetes mellitus, chronic lung diseases, and drug development. Important knowledge gaps in Network Medicine include incompleteness of the molecular interactome, challenges in identifying key genes within genetic association regions, and limited applications to human diseases.

Companion diagnostic for the chloroquine use in the treatment of COVID-19: systems biology report of candidate markers.

“…Systemic network analysis becomes a potent and e cient tool for the investigation of correlations and molecular mechanisms (8,12,13). Well-developed and curated databases contain large volumes of original experimental data.…”

Integrating Genetics and Omics to Understand Chronic Obstructive Pulmonary Disease

“…The recognition that biological systems function as molecular networks has helped to crystallize thinking about combining multiple Omics data in the field of Network Medicine 2,38 . The various methods utilized to build molecular networks have been recently reviewed by members of the International Network Medicine Consortium 39 . Although genetic studies of complex diseases have traditionally focused on analyses of single variants or clustered groups of variants, the role of biological networks has received increased attention through the Omnigenic Model of complex diseases 40 .…”

Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19

“…Such a picture includes the charting of the protein interaction map involving host genes that in the current state of knowledge have been observed to interact with SARS-CoV-2 viral proteins, and/or are considered critical in the host infection processes, also considering previous knowledge related to other relevant Coronaviruses. In the wider context of network medicine ( Bauer-Mehren et al, 2011 ; Silverman and Loscalzo, 2017 ), the protein-protein interaction (PPI) framework provides a widely assessed and effective heuristic approach for the identification of disease genes ( Taylor et al, 2009 ; Gustafsson et al, 2014 ; Tieri et al, 2019 ; Silverman et al, 2020 ). The complexity of the organism’s response to the viral invasion is mirrored by the wide variability of the clinical symptoms observed in patients, ranging from asymptomatic infections to extremely critical conditions, up to the death of the patient in around 3.4% of cases worldwide (see text footnote 1).…”